Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 586, Issue 20, Pages 3737-3745
Publisher
Wiley
Online
2012-09-13
DOI
10.1016/j.febslet.2012.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β associated volume loss occurs only in the presence of phospho-tau
- (2011) Rahul S. Desikan et al. ANNALS OF NEUROLOGY
- Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells
- (2011) Xiong Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
- (2011) Yi-Fei Dong et al. FASEB JOURNAL
- The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
- (2011) Susanne M. Pritchard et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- GSK-3α/β kinases and amyloid production in vivo
- (2011) Tomasz Jaworski et al. NATURE
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid β Metabolism in APP Overexpressing Mice
- (2011) Mahito Yamada et al. PLoS One
- Central Angiotensin II Stimulation Promotes β Amyloid Production in Sprague Dawley Rats
- (2011) Donglin Zhu et al. PLoS One
- Vascular risk factor detection and control may prevent Alzheimer's disease
- (2010) Jack C. de la Torre AGEING RESEARCH REVIEWS
- Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats
- (2010) N. Pelisch et al. AMERICAN JOURNAL OF HYPERTENSION
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway
- (2010) Kun-Lin Chen et al. NEUROBIOLOGY OF DISEASE
- The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond
- (2010) Jack C. de la Torre Neurodegenerative Diseases
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion
- (2010) Kazuo Washida et al. STROKE
- Multiple reprobing of Western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide
- (2009) Alexis D. Sennepin et al. ANALYTICAL BIOCHEMISTRY
- The role of GSK3 in Alzheimer disease
- (2009) Félix Hernández et al. BRAIN RESEARCH BULLETIN
- The brain RAS and Alzheimer's disease
- (2009) John W. Wright et al. EXPERIMENTAL NEUROLOGY
- Angiotensins in Alzheimer's disease – friend or foe?
- (2009) Patrick G. Kehoe et al. TRENDS IN NEUROSCIENCES
- Angiotensins and Alzheimer's disease: a bench to bedside overview
- (2009) Patrick G Kehoe Alzheimers Research & Therapy
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started